Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001811824-25-000002
Filing Date
2025-12-29
Accepted
2025-12-29 17:12:04
Documents
1
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3563
  Complete submission text file 0001811824-25-000002.txt   5046
Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address
Aharon Gil (Reporting) CIK: 0001811824 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41775 | Film No.: 251610086

Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Issuer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)